153,99 €
versandkostenfrei*

inkl. MwSt.
Versandfertig in 2-4 Wochen
77 °P sammeln
    Gebundenes Buch

Chronic Kidney Disease (CKD) is a recognized risk factor for cardiovascular events and death.  The coexistence of CKD and heart failure is increasing in prevalence worldwide and requires a unique and subtle approach to patient management.
 
The Kidney in Heart Failure focuses on the changes that occur in kidney physiology as a function of a failing heart.  This comprehensive resource covers epidemiology, pathophysiology, management of kidney disorders and advances in nephropathy management.  In addition, the latest therapies, common heart failure dilemmas and kidney disease markers are…mehr

Produktbeschreibung
Chronic Kidney Disease (CKD) is a recognized risk factor for cardiovascular events and death.  The coexistence of CKD and heart failure is increasing in prevalence worldwide and requires a unique and subtle approach to patient management.

 

The Kidney in Heart Failure focuses on the changes that occur in kidney physiology as a function of a failing heart.  This comprehensive resource covers epidemiology, pathophysiology, management of kidney disorders and advances in nephropathy management.  In addition, the latest therapies, common heart failure dilemmas and kidney disease markers are included.  Each chapter is co-authored by a Nephrologist and Cardiologist, offering a unified perspective to these chronic conditions.

 

This indispensible volume provides the reader with the depth-of-knowledge needed for assessing and treating the cardio renal patient.
  • Produktdetails
  • Verlag: Springer, Berlin
  • Artikelnr. des Verlages: 12555352
  • 2012
  • Seitenzahl: 264
  • Erscheinungstermin: 11. Juli 2012
  • Englisch
  • Abmessung: 241mm x 160mm x 19mm
  • Gewicht: 530g
  • ISBN-13: 9781461436935
  • ISBN-10: 1461436931
  • Artikelnr.: 35035545
Autorenporträt
Dr. Bakris is currently Professor of Medicine and Director of the Hypertension Center at the University of Chicago Pritzker School of Medicine. Dr. Bakris has published over 600 articles and book chapters in the areas of diabetic kidney disease, hypertension and progression of nephropathy. He is the Editor or Co-Editor of eight books, in the areas of Kidney Disease Progression and Diabetes. Additionally, he is the Associate Editor of the International Textbook of Cardiology. He chaired the first National Kidney Foundation Consensus report on blood pressure and impact on renal disease progression (2000). He has also served on many national guideline committees including: JNC VI and 7 writing committees, the JNC 7 executive committee, the American Diabetes Association Clinical Practice Guideline Committee. Dr. Bakris is also the past-president of the American College of Clinical Pharmacology and the current President of the American Society of Hypertension (ASH) (2010-2012). Heis the current Editor of American Journal of Nephrology and Hypertension, Section Editor of Up-to-Date and Associate Editor of Diabetes Care and Nephrology, Dialysis & Transplant.
Inhaltsangabe
Foreword Peter A. McCulloughPrefacePart One Epidemiology

Chapter 1 Epidemiology of Chronic Kidney Disease in Heart Failure

Ruth C. Campbell and Ali Ahmed

Chapter 2 Anemia and Cardiovascular Risk in the Kidney Disease Patients:

What is the best way to achieve and what is the desired hemoglobin?

Tejas V. Patel and Ajay K. Singh

Part Two PathophysiologyChapter 3 Renal Hemodynamic Changes in Heart Failure

Ivana Lazich and George L. Bakris

Chapter 4 Changes in Kidney Function Following Heart Failure Treatment: Focus on RAS Blockade

Mohammed Shakaib and George L. Bakris

Chapter 5 Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient

Biff F. Palmer

Chapter 6 B-Type Natriuretic Peptide: Beyond Diagnostic Applications

Ivan D. Hanson and Peter A. McCullough

Part Three Management of Kidney Associated Clinical Problems

Chapter 7 Hyperkalemia Risk and Treatment of Heart Failure

Julian Segura and Luis M. Ruilope

Chapter 8 Management of Heart Failure with Renal Artery Ischaemia

Andrew K. Roy and Patrick Murray

Chapter 9 Renal Consequences of Prostaglandin Inhibition in Heart Failure

Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir

Chapter 10 Edema Mechanisms in the Heart Failure Patient and Treatment Options

Domenic A. Sica

Chapter 11 Ultrafiltration and Heart Failure

Paul Chacko, Donald Kikta Jr., William T. Abraham

Part Four Advances in Nephropathy Management: Influences on CVD Risk

Chapter 12 Combination Therapy in Hypertension Treatment

Raymond V. Oliva and George L. Bakris

Chapter 13 Medication Adherence in Heart Failure

Daniel E. Hilleman and Jennifer A. Campbell

Chapter 14 New Markers of Vascular Risk

David Davidson and Michael H. Davidson

Chapter 15 Dietary Paradoxes to Optimize CV Risk Management in CKD

Raghu V. Durvasula and Katherine R. Tuttle

PrefacePart One Epidemiology

Chapter 1 Epidemiology of Chronic Kidney Disease in Heart Failure

Ruth C. Campbell and Ali Ahmed

Chapter 2 Anemia and Cardiovascular Risk in the Kidney Disease Patients:

What is the best way to achieve and what is the desired hemoglobin?

Tejas V. Patel and Ajay K. Singh

Part Two PathophysiologyChapter 3 Renal Hemodynamic Changes in Heart Failure

Ivana Lazich and George L. Bakris

Chapter 4 Changes in Kidney Function Following Heart Failure Treatment: Focus on RAS Blockade

Mohammed Shakaib and George L. Bakris

Chapter 5 Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient

Biff F. Palmer

Chapter 6 B-Type Natriuretic Peptide: Beyond Diagnostic Applications

Ivan D. Hanson and Peter A. McCullough

Part Three Management of Kidney Associated Clinical Problems

Chapter 7 Hyperkalemia Risk and Treatment of Heart Failure

Julian Segura and Luis M. Ruilope

Chapter 8 Management of Heart Failure with Renal Artery Ischaemia

Andrew K. Roy and Patrick Murray

Chapter 9 Renal Consequences of Prostaglandin Inhibition in Heart Failure

Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir

Chapter 10 Edema Mechanisms in the Heart Failure Patient and Treatment Options

Domenic A. Sica

Chapter 11 Ultrafiltration and Heart Failure

Paul Chacko, Donald Kikta Jr., William T. Abraham

Part Four Advances in Nephropathy Management: Influences on CVD Risk

Chapter 12 Combination Therapy in Hypertension Treatment

Raymond V. Oliva and George L. Bakris

Chapter 13 Medication Adherence in Heart Failure

Daniel E. Hilleman and Jennifer A. Campbell

Chapter 14 New Markers of Vascular Risk

David Davidson and Michael H. Davidson

Chapter 15 Dietary Paradoxes to Optimize CV Risk Management in CKD

Raghu V. Durvasula and Katherine R. Tuttle

Ivana Lazich and George L. Bakris

Chapter 4 Changes in Kidney Function Following Heart Failure Treatment: Focus on RAS Blockade

Mohammed Shakaib and George L. Bakris

Chapter 5 Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient

Biff F. Palmer

Chapter 6 B-Type Natriuretic Peptide: Beyond Diagnostic Applications

Ivan D. Hanson and Peter A. McCullough

Part Three Management of Kidney Associated Clinical Problems

Chapter 7 Hyperkalemia Risk and Treatment of Heart Failure

Julian Segura and Luis M. Ruilope

Chapter 8 Management of Heart Failure with Renal Artery Ischaemia

Andrew K. Roy and Patrick Murray

Chapter 9 Renal Consequences of Prostaglandin Inhibition in Heart Failure

Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir

Chapter 10 Edema Mechanisms in the Heart Failure Patient and Treatment Options

Domenic A. Sica

Chapter 11 Ultrafiltration and Heart Failure

Paul Chacko, Donald Kikta Jr., William T. Abraham

Part Four Advances in Nephropathy Management: Influences on CVD Risk

Chapter 12 Combination Therapy in Hypertension Treatment

Raymond V. Oliva and George L. Bakris

Chapter 13 Medication Adherence in Heart Failure

Daniel E. Hilleman and Jennifer A. Campbell

Chapter 14 New Markers of Vascular Risk

David Davidson and Michael H. Davidson

Chapter 15 Dietary Paradoxes to Optimize CV Risk Management in CKD

Raghu V. Durvasula and Katherine R. Tuttle

Mohammed Shakaib and George L. Bakris

Chapter 5 Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient

Biff F. Palmer

Chapter 6 B-Type Natriuretic Peptide: Beyond Diagnostic Applications

Ivan D. Hanson and Peter A. McCullough

Part Three Management of Kidney Associated Clinical Problems

Chapter 7 Hyperkalemia Risk and Treatment of Heart Failure

Julian Segura and Luis M. Ruilope

Chapter 8 Management of Heart Failure with Renal Artery Ischaemia

Andrew K. Roy and Patrick Murray

Chapter 9 Renal Consequences of Prostaglandin Inhibition in Heart Failure

Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir

Chapter 10 Edema Mechanisms in the Heart Failure Patient and Treatment Options

Domenic A. Sica

Chapter 11 Ultrafiltration and Heart Failure

Paul Chacko, Donald Kikta Jr., William T. Abraham

Part Four Advances in Nephropathy Management: Influences on CVD Risk

Chapter 12 Combination Therapy in Hypertension Treatment

Raymond V. Oliva and George L. Bakris

Chapter 13 Medication Adherence in Heart Failure

Daniel E. Hilleman and Jennifer A. Campbell

Chapter 14 New Markers of Vascular Risk

David Davidson and Michael H. Davidson

Chapter 15 Dietary Paradoxes to Optimize CV Risk Management in CKD

Raghu V. Durvasula and Katherine R. Tuttle

Rezensionen
From the reviews:

"This book discusses the epidemiology, pathophysiology, and medical management of kidney disease arising from heart failure. ... designed to support the understanding and management of CKD in patients with heart failure, reviewing current practice in managing cardiorenal syndromes and concluding with advances in nephropathy management in patients ... . Written by respected cardiologists and nephrologists, the book is intended for clinicians in both areas. ... a well-written book that will prove useful in an academic healthcare setting or as continuing education for practice updates." (Melissa K. Soper, Doody's Review Service, January, 2013)